Business
Cube Labs Unit Lipovexa Obtains U.S. Patent For New Therapeutic Platform For Treatment Of Metabolic Disorders
Cube Labs Unit Lipovexa Obtains U.S. Patent For New Therapeutic Platform For Treatment Of Metabolic Disorders
About this update from Cube Labs S.p.a.
Cube Labs SpA MIL:CUBE:UNIT LIPOVEXA OBTAINS U.S. PATENT FOR NEW THERAPEUTIC PLATFORM FOR TREATMENT OF METABOLIC DISORDERS Further company coverage: